Golden State Equity Partners’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Golden State Equity Partners’s Portfolio MRNY Stock Details MRNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.68K	Buy	+90	New	+$1.7K	﹤0.01%	1703

Other funds holding MRNY

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

MCA

McGuire Capital Advisors Bethany, Oklahoma $156M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.07B AUM 4.33% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Golden State Equity Partners's MRNY Position: Q1 2026 in Review

Golden State Equity Partners opened a new position in YieldMax MRNA Option Income Strategy ETF (MRNY) in Q1 2026: 90 shares worth $1.68K. The stake represents ﹤0.01% of the portfolio and ranks #1703 among its holdings.

11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.

Golden State Equity Partners held 90 shares of YieldMax MRNA Option Income Strategy ETF worth $1.68K as of Q1 2026.
YieldMax MRNA Option Income Strategy ETF was a new Golden State Equity Partners position in Q1 2026.
YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Golden State Equity Partners's portfolio in Q1 2026, its #1703 holding.
11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.